Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Nottingham academics develop new nanotechnology to treat brain tumours

04.06.2003


Academics at The University of Nottingham are developing new nanotechnology that could be used to treat brain tumours more effectively by reducing the serious side-effects associated with anti-cancer drugs.

A team led by Dr Martin Garnett in the School of Pharmaceutical Sciences has been awarded a £206,000 grant from the Biotechnology and Biological Sciences Research Council to continue investigations on the preparation of nanoparticles for delivering drugs to brain tumours.

Anti-cancer drugs are problematic because they can cause significant problems in other non-diseased areas of the body too, leading to nasty side effects for the patient. For brain tumours this is doubly difficult because, for most drugs, access to tumours can be even trickier.



The Nottingham academics are looking at changing the behaviour of anti-cancer molecules by putting them into tiny particles called nanoparticles, which are one ten-thousandth of a millimetre in diameter. These nanoparticles are made from polymers - molecules made from a long chain of chemical units. Using a ’’water-loving’’ polymer on the outside, and a ’’water-hating’’ polymer on the inside, allows the particles to assemble themselves with the drugs held in the centre of the nanoparticles.

Because of their size, these nanoparticles can only get out of the blood stream at the tumour and in the liver, preventing toxicity in many other tissues in the body.

The ’’water-loving’’ polymer on the surface of these particles greatly reduces the uptake of the drug to the liver, ensuring that it travels to the brain tumour more effectively. The polymers previously available for making nanoparticles were only capable of carrying small amounts of a drug and couldn’’t hold on to the drug for very long, leading the academics to design some new polymers in an attempt to overcome these problems.

Developing and testing new delivery systems for drugs can also be a problem because of the toxicity of anti-cancer drugs. The academics are overcoming this problem by using drugs that are used to treat the inflammation of the brain that accompanies brain tumours, but are much less harmful to the patient and easier for the researchers to work with.

The idea for this new technology first came as part of discussions within the University’’s Children’’s Brain Tumour Research Centre which involves a number of academics from different disciplines. Co-ordinated by Dr David Walker the centre investigates the causes and potential new treatments for brain tumours in children.

The project is part of a two-centre award from the BBSRC totalling £409,000 which involves the synthesis of new polymers by scientists Dr Gillian Hutcheon and Dr Sean Higgins at Liverpool John Moores University and the development of nanoparticles by Dr Garnett and colleague Dr Paraskevi Kallinteri at The University of Nottingham.

The new project builds on results from a previous BBSRC grant, which have shown that the new polymers have allowed the researchers to incorporate anti-inflammatory drugs into nanoparticles in much greater amounts than with previous polymers and that they also hold on to the drugs much more firmly.

A patent has been filed on the use of these polymers, which should help in the future development of these delivery systems, and the drug release properties of these polymers are now being investigated by research student Weina Meng, whose work has been partly funded by the Children’’s Brain Tumour Research Centre.

The new project will develop these polymers further to discover whether it is possible to incorporate a much wider variety of drugs, including toxic anti-cancer drugs, and also to demonstrate that they work well in test systems.

Dr Garnett said: "I am very pleased with the progress in this project so far. The new polymers have exceeded my expectations and the flexibility of the synthesis of these polymers offers hope that they should be suitable for delivering a wide range of drugs.

"While there is still a long road ahead, we hope that this work will lead to clinical trials of these delivery systems and, eventually, a reduction in the side effects that patients suffer as a result of being treated with anti-cancer drugs."

Lyn Heath-Harvey | alfa
Further information:
http://www.nottingham.ac.uk/public-affairs/index.html

More articles from Health and Medicine:

nachricht Scientists learn more about how gene linked to autism affects brain
19.06.2018 | Cincinnati Children's Hospital Medical Center

nachricht Overdosing on Calcium
19.06.2018 | Albert-Ludwigs-Universität Freiburg im Breisgau

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Temperature-controlled fiber-optic light source with liquid core

In a recent publication in the renowned journal Optica, scientists of Leibniz-Institute of Photonic Technology (Leibniz IPHT) in Jena showed that they can accurately control the optical properties of liquid-core fiber lasers and therefore their spectral band width by temperature and pressure tuning.

Already last year, the researchers provided experimental proof of a new dynamic of hybrid solitons– temporally and spectrally stationary light waves resulting...

Im Focus: Overdosing on Calcium

Nano crystals impact stem cell fate during bone formation

Scientists from the University of Freiburg and the University of Basel identified a master regulator for bone regeneration. Prasad Shastri, Professor of...

Im Focus: AchemAsia 2019 will take place in Shanghai

Moving into its fourth decade, AchemAsia is setting out for new horizons: The International Expo and Innovation Forum for Sustainable Chemical Production will take place from 21-23 May 2019 in Shanghai, China. With an updated event profile, the eleventh edition focusses on topics that are especially relevant for the Chinese process industry, putting a strong emphasis on sustainability and innovation.

Founded in 1989 as a spin-off of ACHEMA to cater to the needs of China’s then developing industry, AchemAsia has since grown into a platform where the latest...

Im Focus: First real-time test of Li-Fi utilization for the industrial Internet of Things

The BMBF-funded OWICELLS project was successfully completed with a final presentation at the BMW plant in Munich. The presentation demonstrated a Li-Fi communication with a mobile robot, while the robot carried out usual production processes (welding, moving and testing parts) in a 5x5m² production cell. The robust, optical wireless transmission is based on spatial diversity; in other words, data is sent and received simultaneously by several LEDs and several photodiodes. The system can transmit data at more than 100 Mbit/s and five milliseconds latency.

Modern production technologies in the automobile industry must become more flexible in order to fulfil individual customer requirements.

Im Focus: Sharp images with flexible fibers

An international team of scientists has discovered a new way to transfer image information through multimodal fibers with almost no distortion - even if the fiber is bent. The results of the study, to which scientist from the Leibniz-Institute of Photonic Technology Jena (Leibniz IPHT) contributed, were published on 6thJune in the highly-cited journal Physical Review Letters.

Endoscopes allow doctors to see into a patient’s body like through a keyhole. Typically, the images are transmitted via a bundle of several hundreds of optical...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Munich conference on asteroid detection, tracking and defense

13.06.2018 | Event News

2nd International Baltic Earth Conference in Denmark: “The Baltic Sea region in Transition”

08.06.2018 | Event News

ISEKI_Food 2018: Conference with Holistic View of Food Production

05.06.2018 | Event News

 
Latest News

Creating a new composite fuel for new-generation fast reactors

20.06.2018 | Materials Sciences

Game-changing finding pushes 3D-printing to the molecular limit

20.06.2018 | Materials Sciences

Could this material enable autonomous vehicles to come to market sooner?

20.06.2018 | Materials Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>